IRIS
CITRO, VALENTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 265
AS - Asia 91
EU - Europa 83
AF - Africa 15
OC - Oceania 1
SA - Sud America 1
Totale 456
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 263
SG - Singapore 40
IT - Italia 39
CN - Cina 37
CI - Costa d'Avorio 15
VN - Vietnam 13
NL - Olanda 9
DE - Germania 8
PL - Polonia 7
FI - Finlandia 6
IE - Irlanda 6
UA - Ucraina 4
CA - Canada 2
CH - Svizzera 1
CZ - Repubblica Ceca 1
FR - Francia 1
GB - Regno Unito 1
NZ - Nuova Zelanda 1
TR - Turchia 1
VE - Venezuela 1
Totale 456
Salva come PNG Salva come JPEG
Città #
Chandler 77
Singapore 31
Santa Clara 23
Beijing 15
Millbury 13
Dong Ket 12
Des Moines 10
Amsterdam 9
Nanjing 9
Princeton 9
Gdansk 7
Naples 6
Boston 5
Jacksonville 5
Afragola 4
Lawrence 4
Ashburn 3
Hebei 3
Munich 3
Nanchang 3
Napoli 3
Tiggiano 3
Changsha 2
Dublin 2
Kronberg 2
Marano Di Napoli 2
Norwalk 2
Ottawa 2
Atlanta 1
Auckland 1
Bacoli 1
Berlin 1
Boardman 1
Brno 1
Busto Arsizio 1
Casavatore 1
Dallas 1
Distrito Federal 1
Helsinki 1
Jiaxing 1
Limatola 1
Manchester 1
Milan 1
Noisy-le-sec 1
Nunziata 1
Pagani 1
Redwood City 1
Rome 1
Rostock 1
Scafati 1
Seattle 1
Shenyang 1
Shenzhen 1
Tianjin 1
Wilmington 1
Zurich 1
Totale 297
Salva come PNG Salva come JPEG
Nome #
A mutant of phosphomannomutase1 retains full enzymatic activity, but is not activated by IMP: Possible implications for the disease PMM2-CDG 49
Heterodimerization of Two Pathological Mutants Enhances the Activity of Human Phosphomannomutase2 45
The Analysis of Variants in the General Population Reveals That PMM2 Is Extremely Tolerant to Missense Mutations and That Diagnosis of PMM2-CDG Can Benefit from the Identification of Modifiers 44
Hematocrit Values Predict Carotid Intimal-Media Thickness in Obese Patients With Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study 41
Identification of an Allosteric Binding Site on Human Lysosomal Alpha-Galactosidase Opens the Way to New Pharmacological Chaperones for Fabry Disease 40
IN SILICO DOCKING OF UROKINASE PLASMINOGEN ACTIVATOR AND INTEGRINS 37
D2A-Ala peptide derived from the urokinase receptor exerts anti-tumoural effects in vitro and in vivo 34
Inherited and Sporadic Epimutations at the IGF2-H19 locus in Beckwith-Wiedemann syndrome and Wilms' tumor. 33
The Large Phenotypic Spectrum of Fabry Disease Requires Graduated Diagnosis and Personalized Therapy: A Meta-Analysis Can Help to Differentiate Missense Mutations 28
Data on the inhibition of cell proliferation and invasion by the D2A-Ala peptide derived from the urokinase receptor 27
In vitro enzyme measurement to test pharmacological chaperone responsiveness in fabry and pompe disease 26
D2A sequence of the urokinase receptor induces cell growth through αvβ3 integrin and EGFR 25
E-learning for marine biotechnology: an example with a metagenomic approach 19
E-Learning for Rare Diseases: An Example Using Fabry Disease 18
PEGYLATION, THE ULTIMATE STRATEGY TO IMPROVE THE IN VIVO EFFICIENCY OF BIOACTIVE COMPOUNDS 18
Totale 484
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.361
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.361
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202023 0 0 0 0 3 0 0 0 0 3 16 1
2020/202129 0 1 0 1 2 6 1 1 4 0 0 13
2021/202254 0 0 1 0 0 0 0 2 4 0 16 31
2022/2023162 14 28 8 7 17 31 1 12 32 7 4 1
2023/202469 5 15 4 3 4 4 0 18 0 0 10 6
2024/202567 18 30 2 2 15 0 0 0 0 0 0 0
Totale 484